Eljee66 schreef op 25 maart 2025 17:19:
Dit was dus de reden
Paris, France, and Manchester, UK – 18 March 2025 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, provides an update further to the Health and Safety Executive (“HSE”) Prosecution announcement made on 21 January 2025 (RNS: 1680U).
Lab21 Healthcare Ltd (“Lab 21”), a non-trading subsidiary of Novacyt, has pleaded guilty at Exeter Magistrates Court today to health and safety charges relating to the historical operation of its site in Axminster, Devon between 28 June 2018 and 5 April 2019.
The Company has co-operated with the HSE throughout the investigation and the Lab 21 operations no longer form any part of the Novacyt’s ongoing business. The lease for the site was originally taken over as part of an acquisition announced on 28 June 2018.
The sentencing hearing is currently planned to be held on the 11 September 2025 to determine the applicable penalty. A further announcement will be made following the outcome.